BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37583856)

  • 1. Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report.
    Jeon SY; Lee NR; Cha S; Yhim HY; Kwak JY; Jang KY; Kim N; Cho YG; Lee CH
    World J Clin Cases; 2023 Jul; 11(21):5129-5135. PubMed ID: 37583856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aleukemic extramedullary T lymphoid/myeloid bilineage hematopoietic and lymphoid malignancy with progression to bilineage leukemia at relapse: A case report.
    Wu M; Li X; Tang F; Zhu P; Ding T; Yuan Y; Chen T
    Oncol Lett; 2017 Dec; 14(6):7723-7732. PubMed ID: 29344217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia with T lymphoblastic lymphoma: a case report and literature review.
    Gao Y; Feng XQ; Liu SS; Xu YJ; Mao CX; Li TL; Hou F; Zhang W
    J Int Med Res; 2021 May; 49(5):3000605211016138. PubMed ID: 34038217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
    Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
    Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of Non-Hodgkin's Lymphoma and Acute Myeloid Leukemia at Initial Diagnosis: A Case Report.
    Ke MM; Wang ZZ; Wan Q; Chen ZJ
    Curr Med Imaging; 2023; 19(10):1219-1223. PubMed ID: 36177617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
    Provez L; Putteman T; Landfors M; Roels J; Reunes L; T'Sas S; Van Loocke W; Lintermans B; De Coninck S; Thenoz M; Sleeckx W; Maćkowska-Maślak N; Taghon T; Mansour MR; Farah N; Norga K; Vandenberghe P; Kotecha RS; Goossens S; Degerman S; De Smedt R; Van Vlierberghe P
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.
    Akiely R; Almasri F; Almasri N; Abu-Ghosh A
    Front Pediatr; 2022; 10():1059527. PubMed ID: 36589160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience.
    Chen Y; Cao J; Ye Y; Luo L; Zheng X; Yang X; Zheng Z; Zheng J; Yang T; Hu J
    J Chemother; 2023 Jul; 35(4):322-329. PubMed ID: 35881409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
    Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.
    Lübbert M; Rüter BH; Claus R; Schmoor C; Schmid M; Germing U; Kuendgen A; Rethwisch V; Ganser A; Platzbecker U; Galm O; Brugger W; Heil G; Hackanson B; Deschler B; Döhner K; Hagemeijer A; Wijermans PW; Döhner H
    Haematologica; 2012 Mar; 97(3):393-401. PubMed ID: 22058219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: Two case reports and a literature review.
    Fu X; Shang Y; Zhang L; Li L; Li X; Wang X; Sun Z; Zhang M
    Oncol Lett; 2018 Nov; 16(5):6624-6632. PubMed ID: 30405801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
    Kantarjian HM; Begna KH; Altman JK; Goldberg SL; Sekeres MA; Strickland SA; Arellano ML; Claxton DF; Baer MR; Gautier M; Berman E; Seiter K; Solomon SR; Schiller GJ; Luger SM; Butrym A; Gaidano G; Thomas XG; Montesinos P; Rizzieri DA; Quick DP; Venugopal P; Gaur R; Maness LJ; Kadia TM; Ravandi F; Buyse ME; Chiao JH
    Cancer; 2021 Dec; 127(23):4421-4431. PubMed ID: 34424530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.
    Ma YY; Zhang QC; Tan X; Zhang X; Zhang C
    World J Clin Cases; 2021 Nov; 9(31):9607-9616. PubMed ID: 34877297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report.
    Liu H; Cheng J; Zhao L; Xu Q; Xue M; Zhang S; Liu B
    Oncol Lett; 2018 May; 15(5):7132-7138. PubMed ID: 29731877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent precursor-B acute lymphoblastic leukemia presenting as a cervical malignancy.
    Kazi S; Szporn AH; Strauchen JA; Chen H; Kalir T
    Int J Gynecol Pathol; 2013 Mar; 32(2):234-7. PubMed ID: 23370653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report.
    Park S; Jeong EJ; Kang JH; Lee GW; Go SI; Lee DH; Koh EH
    World J Clin Cases; 2023 Sep; 11(26):6200-6205. PubMed ID: 37731550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study.
    Guo Z; Guo D; Kong D; Bian S; Lin L; Fan S; Li Q; Zhao Y; Jiang Y; Yan J; Wang Z; Sun L; Li Y
    Hematology; 2023 Dec; 28(1):2219930. PubMed ID: 37278601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.